These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6739537)

  • 1. Acute effects of the synthetic analogue of methionine enkephalin FK 33-824 in schizophrenic patients. A double blind trial.
    Jungkunz G; Nedopil N; Rüther E
    Pharmacopsychiatry; 1984 May; 17(3):76-8. PubMed ID: 6739537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute effects of the synthetic analogue of methionine enkephalin FK 33-824 on depressive symptoms.
    Jungkunz G; Nedopil N; Rüther E
    Pharmacopsychiatria; 1983 May; 16(3):90-2. PubMed ID: 6351118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enkephalin analogue in schizophrenia. Double blind cross-over trial.
    Joergensen A; Fog R
    Acta Psychiatr Scand; 1986 Jan; 73(1):45-8. PubMed ID: 3515852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of a synthetic analog of enkephalin on the choreic syndrome].
    Destée A; Petit H; Warot P; Lhermitte F; Agid Y
    Rev Neurol (Paris); 1982; 138(11):845-9. PubMed ID: 6762632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Des-tyrosyl-gamma-endorphin in schizophrenia: a double-blind trial in 13 patients.
    Emrich HM; Zaudig M; Kissling W; Dirlich G; von Zerssen D; Herz A
    Pharmakopsychiatr Neuropsychopharmakol; 1980 Sep; 13(5):290-8. PubMed ID: 7003611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms: a randomized double-blind multicenter trial.
    Möller HJ; Riedel M; Müller N; Fischer W; Kohnen R
    Pharmacopsychiatry; 2004 Nov; 37(6):270-8. PubMed ID: 15551193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High vs standard dosage fluphenazine HCL in acute schizophrenia.
    Donlon PT; Meadow A; Tupin JP; Wahba M
    J Clin Psychiatry; 1978 Nov; 39(11):800-4. PubMed ID: 363702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment with bromperidol in schizophrenic patients].
    Ellerman LA
    Acta Psiquiatr Psicol Am Lat; 1989; 35(1-2):23-30. PubMed ID: 2634329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the synthetic analogue of methionine enkephalin FK 33-824 on psychotic symptoms.
    Nedopil N; Rüther E
    Pharmakopsychiatr Neuropsychopharmakol; 1979 May; 12(3):277-80. PubMed ID: 482351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Benzodiazepine monotherapy in acute schizophrenia].
    Jaspert A; Ebert D
    Nervenarzt; 1994 Jan; 65(1):62-5. PubMed ID: 7908419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of sustained attention and visual and movement skills, but not clinical symptoms, after dehydroepiandrosterone augmentation in schizophrenia: a randomized, double-blind, placebo-controlled, crossover trial.
    Ritsner MS; Gibel A; Ratner Y; Tsinovoy G; Strous RD
    J Clin Psychopharmacol; 2006 Oct; 26(5):495-9. PubMed ID: 16974191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Is there a special indication for fluphenazine in therapy refractory hallucinations?].
    Bechter K
    Nervenarzt; 1994 Nov; 65(11):798-801. PubMed ID: 7816159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Double-blind comparison of 3 x 75 mg zotepine und 3 x 4 mg haloperidol in acute schizophrenic patients].
    Klieser E; Lehmann E; Tegeler J
    Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():14-7. PubMed ID: 1683333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of efficacy of zotepine and thiothixene in schizophrenia in a double-blind study.
    Sarai K; Okada M
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):38-46. PubMed ID: 2883680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trial.
    Akhondzadeh S; Safarcherati A; Amini H
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):253-9. PubMed ID: 15694232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of a synthetic enkephalin analogue during heroin withdrawal.
    Holmstrand J; Gunne LM
    Pharmakopsychiatr Neuropsychopharmakol; 1980 Mar; 13(2):68-71. PubMed ID: 7437134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effectiveness and tolerance of zotepine in a double-blind comparison with perazine in schizophrenic patients].
    Dieterle DM; Müller-Spahn F; Ackenheil M
    Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():18-22. PubMed ID: 1683334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a methionine-enkephalin analog in Huntington's disease.
    Agid Y; Destee A; Lallemand A
    Adv Neurol; 1983; 37():299-304. PubMed ID: 6222636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Zotepine versus perazine in patients with paranoid schizophrenia: a double-blind controlled trial of its effectiveness].
    Wetzel H; von Bardeleben U; Holsboer F; Benkert O
    Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():23-9. PubMed ID: 1683336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No evidence of antipsychotic effect of caerulein in schizophrenic patients free of neuroleptics: a double-blind cross-over study.
    Lotstra F; Verbanck P; Mendlewicz J; Vanderhaeghen JJ
    Biol Psychiatry; 1984 Jun; 19(6):877-82. PubMed ID: 6378259
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.